
Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 07, 2023, titled "Venus Remedies Awarded Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities.".
Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 07, 2023, titled "Venus Remedies Awarded Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities.".
6ix hasn’t read this filing yet.
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies